The reduced tumor bulk and enhanced immune infiltration observed pathologically may reflect the dual mechanism of immunochemotherapy, namely cytotoxic chemotherapy makes the tumors reduced, while ICIs sustain anti-tumor immunity by blocking PD-1/PD-L1-mediated T-cell exhaustion. The gene discussed is CD274; the disease is neoplasm.